Testing a patient’s immune cells for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a modified version of your own immune cells (made from your blood) to help treat advanced cancers that are no longer responding to standard treatment. It’s designed mainly to see if the approach is safe and how well it may work for people whose disease has progressed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) must be at least 8 years old, or have parent permission if younger
- Your doctor must confirm you have advanced cholangiocarcinoma or neuroblastoma
- Your cancer must have stopped responding to current treatments
- Your health must be good enough for treatment (ECOG score of 0, 1, or 2)
- Blood tests must meet minimum levels (like hemoglobin, white blood cells, and platelets)
- You must be able to follow the trial rules and sign written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests specially prepared immune cells (called CIML-NK cells) from a partially matched family donor to fight neuroblastoma that has returned or stopped responding to standard treatment. The goal is to see if these cells can help patients whose cancer is difficult to control.
This trial tests a new immune cell therapy for people with advanced solid tumors (lung, liver, colorectal, or breast cancer). It aims to use your own immune cells to fight the cancer, and might help if standard treatments have stopped working.
This trial tests whether adding special immune cells (iNKT cells and CD8+ T cells) given by IV infusion can help treat advanced cancers. It mainly looks at safety first, and also checks whether the treatment can shrink or control cancer.
This trial tests a new treatment using natural killer (NK) cells, a type of immune cell, to fight advanced solid tumors. It may be an option if standard treatments have stopped working or are not available.
This trial tests a new treatment made from your own immune cells (called tumor-infiltrating lymphocytes) that are genetically modified to fight cancer better. It is for people with certain advanced solid tumors that have not responded well to other treatments.
This trial tests a personalized treatment that uses your own immune cells, specially trained to find and attack your tumor. It is for people with advanced solid tumors that have not responded to standard treatments.
Hear when a new Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.